
Validea's guru fundamental report rates Visa (V) at 79% using its Warren Buffett-inspired "Patient Investor" model, which prioritizes long-term, predictable profitability, low debt, and reasonable valuations. The large-cap growth stock passes most key criteria, including earnings predictability, return on equity, and free cash flow, indicating strong underlying fundamentals. However, it fails on "Initial Rate of Return," suggesting that while fundamentally sound, its current valuation might temper the model's highest level of interest.
Visa Inc. (V) scores a 79% rating from Validea's "Patient Investor" model, which is based on Warren Buffett's investment criteria, placing it just below the 80% threshold for a stock of interest. The company exhibits strong underlying fundamentals, passing key tests for earnings predictability, return on equity, return on assets, and free cash flow generation. Furthermore, the model positively assesses Visa's use of retained earnings and its share repurchase program, indicating effective capital management consistent with shareholder value creation. The primary detractor from a higher score is the stock's failure on the "Initial Rate of Return" criterion. This specific failure suggests that while Visa is a high-quality enterprise with predictable profitability, its current market valuation may not offer the margin of safety or immediate return potential typically sought by this value-oriented strategy, tempering the otherwise bullish fundamental assessment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment